$634.17K in average volume shows that Replimune Group Inc (REPL) is heading in the right direction

On Friday, Replimune Group Inc (NASDAQ: REPL) opened lower -5.26% from the last session, before settling in for the closing price of $11.40. Price fluctuations for REPL have ranged from $4.92 to $12.97 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Company’s average yearly earnings per share was noted 10.26% at the time writing. With a float of $54.53 million, this company’s outstanding shares have now reached $61.42 million.

Let’s determine the extent of company efficiency that accounts for 331 employees. In terms of profitability, gross margin is 48.27%, operating margin of -5729.32%, and the pretax margin is -5260.12%.

Replimune Group Inc (REPL) Insider Activity

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Replimune Group Inc is 23.22%, while institutional ownership is 89.48%. The most recent insider transaction that took place on Aug 16 ’24, was worth 90,989. In this transaction Chief Financial Officer of this company sold 8,938 shares at a rate of $10.18, taking the stock ownership to the 101,057 shares. Before that another transaction happened on Jun 07 ’24, when Company’s Chief Medical Officer sold 15,881 for $7.50, making the entire transaction worth $119,108. This insider now owns 117,131 shares in total.

Replimune Group Inc (REPL) Earnings and Forecasts

If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.77 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.94) by 0.17. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.76 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 10.26% per share during the next fiscal year.

Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators

Check out the current performance indicators for Replimune Group Inc (REPL). In the past quarter, the stock posted a quick ratio of 10.11.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.12, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -2.60 in one year’s time.

Technical Analysis of Replimune Group Inc (REPL)

Looking closely at Replimune Group Inc (NASDAQ: REPL), its last 5-days average volume was 0.51 million, which is a drop from its year-to-date volume of 1.03 million. As of the previous 9 days, the stock’s Stochastic %D was 15.32%. Additionally, its Average True Range was 0.70.

During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 57.53%, which indicates a significant increase from 8.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.59% in the past 14 days, which was lower than the 59.25% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $11.46, while its 200-day Moving Average is $9.04. However, in the short run, Replimune Group Inc’s stock first resistance to watch stands at $11.34. Second resistance stands at $11.87. The third major resistance level sits at $12.25. If the price goes on to break the first support level at $10.43, it is likely to go to the next support level at $10.05. Should the price break the second support level, the third support level stands at $9.52.

Replimune Group Inc (NASDAQ: REPL) Key Stats

There are currently 68,417K shares outstanding in the company with a market cap of 700.02 million. Presently, the company’s annual sales total 0 K according to its annual income of -215,790 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -53,770 K.